It's a new year, and many top drugmakers are again raising their prices. Pfizer and Bristol-Myers' Eliquis, Gilead's Truvada and hundreds of other branded medicines have higher list prices after Jan. 1, GoodRx reports. And AbbVie raised the price of its bestselling Humira by 7.4%, according to an analyst.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,